Covered recipient · General Payments record
JACQUELINE SKARRE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,648.53
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $415.52 | 5 |
| Consulting Fee | $200.00 | 1 |
| Education | $169.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $200.00 | 1 |
| Actelion Pharmaceuticals US, Inc. | $169.98 | 2 |
| Merck Sharp & Dohme Corporation | $156.72 | 2 |
| United Therapeutics Corporation | $133.80 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $79.99 | 07/24/2024 | Education | Undisputed | 01/23/2026 | 1078905567 | CMS |
| Actelion Pharmaceuticals US, Inc. | $89.99 | 10/17/2024 | Education | Undisputed | 01/23/2026 | 1078905557 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1086311315 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.00 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118067447 | CMS |
| Merck Sharp & Dohme LLC | $31.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141712495 | CMS |
| Merck Sharp & Dohme LLC | $124.77 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141874177 | CMS |
| United Therapeutics Corporation | $25.00 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149451827 | CMS |
| United Therapeutics Corporation | $108.80 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149445336 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.